The power of digital-data platforms: Head-to-head comparison of the safety and efficacy of three phosphodiesterase type 5 inhibitors in >130,000 patients

Authors
Category Primary study
ConferenceEAU25 - 40th Annual EAU Congress
Year 2025
This article has no abstract
Epistemonikos ID: 2fb8ee9f6bf14d5c670fa29e947f0451ffc57472
First added on: Oct 25, 2025